NLRP3 and liver dysplastic nodule: TXNIP inhibitor (ruscogenin) also suppressed TXNIP, NLRP3, and caspase-1 protein expressions and decreased IL-1β levels in renal tissue of mice with DN by treated with Schisandrin A (Figures 6(c) and 6(d)).